Results 101 to 110 of about 696,003 (270)
Background: Strategies are needed to improve oral rotavirus vaccine (RV), which provides suboptimal protection in developing countries. Probiotics and zinc supplementation could improve RV immunogenicity by altering the intestinal microbiota and immune ...
R. Lazarus +21 more
semanticscholar +1 more source
Introducing rotavirus vaccine in eight sub-Saharan African countries: a cost–benefit analysis
Background: Stimulated by the economic challenges faced by many sub-Saharan African countries and the changes in the rotavirus burden across these countries, this study aimed to inform the decision of health policy makers of eight sub-Saharan countries ...
Okafor, Charles E, Ekwunife, Obinna I
core +1 more source
Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland
Objective: To assess the impact of introducing a publicly funded infant rotavirus vaccination program on disease notifications and on laboratory testing and results.
Faux, Cassandra E +8 more
core +2 more sources
This study performs pan‐viromic profiling of 14,529 samples from 5,710 domestic herbivores across five Chinese provinces, establishing the DhCN‐Virome (1,085,360 viral metagenomes). It reveals species/sample‐specific viromic signatures and cross‐species transmission dynamics, aiding unified disease control.
Yue Sun +19 more
wiley +1 more source
Rotavirus is the leading cause of childhood deaths due to diarrhea. Although existing oral rotavirus vaccines are highly efficacious in high-income countries, these vaccines have been demonstrated to have decreased efficacy in low- and middle-income ...
J. Fix +9 more
semanticscholar +1 more source
ABSTRACT Background and Aims Rotavirus is a leading cause of severe diarrhoeal disease in young children worldwide. In 2024, Iran introduced the pentavalent oral vaccine Rotasiil® into its national immunization program. This study aimed to estimate its potential epidemiological impact using an agent‐based modeling (ABM) approach.
Amirhesam Moosazadeh +2 more
wiley +1 more source
Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors
Rotaviruses are a major cause of acute gastroenteritis in infants and young children worldwide and in many other mammalian and avian host species. Since 2006, two live-attenuated rotavirus vaccines, Rotarix® and RotaTeq®, have been licensed in >100 ...
U. Desselberger
semanticscholar +1 more source
Since the presentation of the clinical trial reports showing the excellent efficacy and safety of the two human rotavirus vaccines (Rotarix and RotaTeq), the human rotavirus vaccines have received worldwide attention. The two vaccines have been approved in more than 100 countries, and were included in routine immunization schedule in about 30 countries.
openaire +3 more sources
A Protocol of National Mixed‐Methods Assessment of Childhood and Maternal Immunization
ABSTRACT Background and Aims Accurate measurement of routine immunization coverage is essential for detecting immunity gaps, guiding programmatic responses, and supporting equitable vaccine delivery. Iran's Expanded Programme on Immunization has achieved high coverage, but administrative estimates can mask some disparities.
Seyed Aria Nejadghaderi +8 more
wiley +1 more source
Rotavirus vaccines and vaccination in Latin America [PDF]
Worldwide, rotaviruses account for more than 125 million cases of infantile gastroenteritis and nearly 1 million deaths per year, mainly in developing countries. Rather than other control measures, vaccination is most likely to have a major impact on rotavirus disease incidence. The peak incidence of rotavirus diarrhea occurs between 6 and 24 months of
A C, Linhares, J S, Bresee
openaire +2 more sources

